Sökning: onr:"swepub:oai:DiVA.org:uu-14996" >
Genotoxic hazard of...
-
Lundqvist, HansUppsala universitet,Enheten för biomedicinsk strålningsvetenskap
(författare)
Genotoxic hazard of radiopharmaceuticals in humans : chemical and radiation aspects coupled to microdosing
- Artikel/kapitelEngelska2007
Förlag, utgivningsår, omfång ...
-
2007-04-25
-
Springer Science and Business Media LLC,2007
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-14996
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-14996URI
-
https://doi.org/10.1007/s00228-007-0304-6DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Introduction To obtain the pharmacokinetic properties of drug candidates at an early stage of the development process, a microdosing (phase 0) concept to radiolabel drug candidates and administer them at subtoxic mass to a few volunteers has been suggested. Radiopharmaceuticals are special in the sense that the chemical carrier might be genotoxic, whereas it is well established that ionizing radiation coupled to the molecule is genotoxic, and that the mechanism that causes cancer is similar to certain genotoxic chemicals. Regulatory perspectives of the levels of toxicity An analysis shows that, e.g., positron emission tomography (PET) pharmaceuticals carry a mass less than what is regarded as an acceptable level of a genotoxic impurity. It has also been shown that the estimated genotoxicity hazard of the radioactivity is 10–100 times higher than that of the administered chemicals. Conclusion As radiation doses at this level are accepted in clinical trials, the conclusion is that the regulatory demands on radiopharmaceuticals produced at high specific radioactivity should be reconsidered in order to facilitate the use of the microdosing concept for drug development.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Antoni, Gunnar
(författare)
-
Långström, BengtUppsala universitet,Institutionen för biokemi och organisk kemi(Swepub:uu)benglang
(författare)
-
Uppsala universitetEnheten för biomedicinsk strålningsvetenskap
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:European Journal of Clinical Pharmacology: Springer Science and Business Media LLC63:7, s. 641-6450031-69701432-1041
Internetlänk
Hitta via bibliotek
Till lärosätets databas